Publications by authors named "Meifang Han"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

176

Total Likes

89

Extended Reach

473,760

Social Features

106
E
Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trial.
Di Wu, Da Huang, Shifang Peng, Yongping Chen, Fengchun Yang, Xiaoyun Zhang, Meifang Han

Hepatol Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Throughput Viral Integration Detection Reveals Baseline Breakpoints Burden Associated With HBsAg Seroclearance.
Misi Gu, Wenyu Wu, Jie You, Qianjun Wu, Fei Huang, Yixuan Zhang, Meifang Han

Aliment Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: HBV Integration-A Possible Key Driver on the Course of Patients With Chronic HBV Infection Under Viral Suppression. Authors' Reply.
Qin Ning, Meifang Han

Aliment Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0.
Di Wu, Jia-Horng Kao, Teerha Piratvisuth, Xiaojing Wang, Patrick T F Kennedy, Wenhong Zhang, Meifang Han

Clin Mol Hepatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLD.
Danqing Hu, Peng Wang, Xiaojing Wang, Xue Hu, Da Huang, Meifang Han

J Formos Med Assoc· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis.
Danqing Hu, Peng Wang, Xiaojing Wang, Xue Hu, Da Huang, Meifang Han

Heliyon· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research on the influence mechanism of green finance on the quality of green innovation of private enterprises: evidence from China.
Deshan Li, Chenyang Gou, Meifang Han

Environ Sci Pollut Res Int· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGL2-MCOLN3-Autophagy Axis-Triggered Neutrophil Extracellular Traps Exacerbate Liver Injury in Fulminant Viral Hepatitis.
Xitang Li, Qiang Gao, Wenhui Wu, Suping Hai, Junjian Hu, Meifang Han

Cell Mol Gastroenterol Hepatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB.
Da Huang, Di Wu, Peng Wang, Yongli Wang, Wei Yuan, Xiaoping Zhang, Meifang Han

J Hepatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic exosomes with declined MiR-27b-3p trigger RIG-I/TBK1 signal pathway in macrophages.
Jie You, Wenyu Wu, Mengxin Lu, Yanghao Xie, Rui Miao, Meifang Han

Liver Int· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China.
Tingting Liu, Di Wu, Weiming Yan, Xiaojing Wang, Xiaoyun Zhang, Meifang Han

Clin Infect Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.
Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Meifang Han

Signal Transduct Target Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insufficient immunity led to virologic breakthrough in NAs-treated chronic hepatitis B patients switching to Peg-IFN-ɑ.
Da Huang, Weiming Yan, Meifang Han, Wei Yuan, Peng Wang

Antiviral Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated Interferon-ɑ (IFN-ɑ) Enhances the Inhibitory Effect of Natural Killer Cells on Regulatory T Cells via IFN-γ in Chronic Hepatitis B.
Wei Yuan, Da Huang, Di Wu, Yuying Chen, Ke Ma, Meifang Han

J Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection.
Yuying Chen, Da Huang, Wei Yuan, Jiang Chang, Zhize Yuan, Meifang Han

Infect Dis Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical analysis and a novel risk predictive nomogram for 155 adult patients with hemophagocytic lymphohistiocytosis.
Mengxin Lu, Yanghao Xie, Xiaoxu Guan, Ming Wang, Lin Zhu, Shen Zhang, Meifang Han

Ann Hematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential immune regulation benefit of CpAMs beyond HBV suppression.
Di Wu, Weiming Yan, Meifang Han, Qin Ning

Lancet Gastroenterol Hepatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
Meifang Han, Ke Ma, Xiaojing Wang, Weiming Yan, Hongwu Wang

Front Endocrinol (Lausanne)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAPRL Scoring System for Prediction of 30-day Mortality in 949 Patients with Coronavirus Disease 2019 in Wuhan, China: A Retrospective, Observational Study.
Hui-Long Chen, Wei-Ming Yan, Guang Chen, Xiao-Yun Zhang, Zhi-Lin Zeng, Shen Zhang, Xiao-Ping Zhang, Mei-Fang Han

Infect Dis Immun· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-Induced Macrophage-Derived Exosomes Mediate Antiviral Activity Against Hepatitis B Virus Through miR-574-5p.
Wenyu Wu, Di Wu, Weiming Yan, Yongli Wang, Jie You, Meifang Han

J Infect Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China.
Ming Wang, Weiming Yan, Weipeng Qi, Di Wu, Lin Zhu, Meifang Han

Hepatol Int· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
Zhilin Zeng, Haijing Yu, Huilong Chen, Weipeng Qi, Liang Chen, Meifang Han

Crit Care· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Jia Wei, Jianping Zhao, Meifang Han, Fankai Meng, Jianfeng Zhou

J Immunother Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.
Tao Chen, Di Wu, Huilong Chen, Weiming Yan, Danlei Yang, Xiaoping Zhang, Meifang Han

BMJ· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis